Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

Hikmat N. Razeq-Abdel

Amman, AM, JO 
Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
Amman, AM, JO 
OverviewLocationsClinical Research

Overview

Hikmat Razeq-Abdel practices in Amman, Jordan. Razeq-Abdel is rated as an Advanced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Their top areas of expertise are Breast Cancer, BRCA Positive Breast Cancer, Venous Thromboembolism (VTE), Salpingo-Oophorectomy, and Mastectomy.

Their clinical research consists of co-authoring 151 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).

Locations

Amman, AM, Jordan
Other Locations
Al Jubayhah, AM 11941, Jordan
Jordan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
Enrollment Status: Completed
Publish Date: March 19, 2025
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
Enrollment Status: Completed
Publish Date: March 19, 2025
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 PatiEnts: A Pilot, Multicenter Randomized Open-Label Trial
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 PatiEnts: A Pilot, Multicenter Randomized Open-Label Trial
Enrollment Status: Withdrawn
Publish Date: May 27, 2022
Intervention Type: Drug
Study Phase: Not Applicable
A Multicenter, Open-label, Pilot Study on Using Hydroxychloroquine (HCQ) and Azithromycin (AZ) Prophylaxis for Healthcare Workers With a Potential Risk of Exposure to COVID-19 Patients
A Multicenter, Open-label, Pilot Study on Using Hydroxychloroquine (HCQ) and Azithromycin (AZ) Prophylaxis for Healthcare Workers With a Potential Risk of Exposure to COVID-19 Patients
Enrollment Status: Withdrawn
Publish Date: October 26, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 3 Less Clinical Trials

151 Total Publications

Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment.
Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment.
Journal: JCO global oncology
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Razeq-Abdel's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile